Genetics of Frontotemporal Dementia

Area of Science:

• Neuroscience
• Genetics
• Neurology

Background:

• Frontotemporal dementia (FTD) is the second leading cause of dementia after Alzheimer's disease (AD).
• Familial cases constitute 20-50% of FTD, with known genetic mutations in MAPT, GRN, and C9orf72.
• C9orf72 mutations are the most prevalent genetic cause, accounting for 25% of familial FTD.

Purpose of the Study:

• To provide a comprehensive review of Frontotemporal Dementia (FTD).
• To cover the genetics, clinical aspects, diagnostics, and therapeutics of FTD.
• To highlight diagnostic challenges due to overlapping symptoms with other conditions like AD.

Main Methods:

• Review of existing literature on FTD genetics, clinical presentations, neuroimaging, and neuropathology.
• Inclusion of animal studies and therapeutic trial data.
• Discussion of specific genetic mutations and clinical case studies.

Main Results:

• Identified key genetic mutations (MAPT, GRN, C9orf72) responsible for a significant portion of familial FTD.
• Highlighted C9orf72 as the most common genetic mutation.
• Discussed rarer mutations in genes like VPC, CHMP2B, TARDP, FUS, ITM2B, TBK1, and TBP.

Conclusions:

• FTD diagnosis is complex due to symptom overlap with other neurodegenerative diseases.
• Understanding the genetic underpinnings is crucial for FTD diagnosis and research.
• Ongoing research into genetics and therapeutics offers hope for improved FTD management.